Biohaven Pharmaceutical Holding (BHVN) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Where to Rent Stable Turkish Datacenter Proxies?

July 1, 2025 Where to Rent Stable Turkish Datacenter Proxies?

In a digital landscape where online anonymity and efficiency are essential, datacenter proxies have become a fundamental tool for businesses, SEO specialists, and…
PayPal’s News Analysis—A Short and Medium-Term Price Forecast

June 24, 2025 PayPal’s News Analysis—A Short and Medium-Term Price Forecast

This analytical article cuts through the noise, offering a focused forecast for PYPL’s stock price movement in both the short (5 days) and…
Understanding Accounting and Bookkeeping Services for Business Success

June 10, 2025 Understanding Accounting and Bookkeeping Services for Business Success

Every successful business relies on accurate financial records. From managing cash flow to ensuring compliance with tax regulations, reliable accounting and bookkeeping services…
How much does a Turkish passport cost?

May 27, 2025 How much does a Turkish passport cost?

Turkish citizenship comes with numerous benefits. Once granted, a foreigner can enter 126 countries visa-free, enjoy high-quality healthcare and favorable tax regimes, and…
How Measurement and Mix Modeling Drive Better Business Decisions

May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions

In today’s data-driven business landscape, the ability to accurately measure and optimize marketing efforts has become a critical competitive advantage. As marketing evolves,…

Biohaven Pharmaceutical Holding (BHVN) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: July 7, 2025 (19:51)

Sector: Healthcare

The share price of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) now

Latest session on the 3rd of July for
Biohaven Pharmaceutical Holding Company Ltd. is negative
Trading Volume: 753892
Open: 14.74 /  High: 14.96 /  Low: 14.405
Current value: $14.63
What analysts predict: $56.08
52-week High/Low: $55.7 / $14.33
50-Day Moving Average: $20.78 — resistance level today
200-Day Moving Average: $36.53 — resistance level today

Are you interested in Biohaven Pharmaceutical Holding Company Ltd. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Biohaven Pharmaceutical Holding stock price in 2025, 2026, 2027. How much will one Biohaven Pharmaceutical Holding share be worth in 2025 - 2027?

When should I take profit in Biohaven Pharmaceutical Holding stock? When should I record a loss on Biohaven Pharmaceutical Holding stock? What are analysts' forecasts for Biohaven Pharmaceutical Holding stock? What is the future of Biohaven Pharmaceutical Holding stock? We forecast Biohaven Pharmaceutical Holding stock performance using neural networks based on historical data on Biohaven Pharmaceutical Holding stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Biohaven Pharmaceutical Holding stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Biohaven Pharmaceutical Holding shares. This happens once a day.


Historical and forecast chart of Biohaven Pharmaceutical Holding stock

The chart below shows the historical price of Biohaven Pharmaceutical Holding stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Biohaven Pharmaceutical Holding stock price can be found in the table below.

Long-term forecasts by years.

Biohaven Pharmaceutical Holding Company Ltd., a clinical stage biopharmaceutical company, is developing advanced candidate products targeting neurological diseases and rare disorders in the United States. Its clinical stage products include Rimehepant, a product that has completed phase III trials for the acute treatment and prevention of migraines; Vasegepant, which has completed phase 2/3 trials for acute treatment and prevention of migraine; and Troriluzole, which has completed phase II / III randomization and is continuing with extended trials for ataxia. The company also offers Troril uzole, which is a phase II / III clinical stage for obsessive-compulsive disorder and Alzheimer’s disease; BHV-0223, product for amyotrophic lateral sclerosis; BHV-5000, a product that has completed phase I clinical trials for neuropsychiatric disorders; and Verdiperstat, a product that is in phase III clinical trials for multiple systemic atrophy. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine assessment of migraine sufferers. The company was founded in 2013 and is headquartered in New Haven, Connecticut.

Trending Themes in the Healthcare Sector

Biohaven Pharmaceutical Holding daily forecast for a month

Date Target Pes. Opt. Vol., %
Jul 09 14.44 14.13 14.59 3.28
Jul 10 14.28 14.02 14.57 3.88
Jul 11 14.34 14.15 14.56 2.86
Jul 12 14.52 14.28 14.75 3.29
Jul 13 14.34 14.06 14.49 3.09
Jul 14 14.36 14.23 14.63 2.78
Jul 15 14.16 13.97 14.27 2.16
Jul 16 14.35 14.23 14.50 1.85
Jul 17 14.55 14.46 14.89 2.99
Jul 18 14.74 14.40 14.99 4.08
Jul 19 14.57 14.44 14.78 2.36
Jul 20 14.81 14.63 15.02 2.67
Jul 21 14.71 14.48 14.85 2.62
Jul 22 14.92 14.79 15.16 2.48
Jul 23 14.81 14.72 14.91 1.30
Jul 24 15.24 15.14 15.50 2.42
Jul 25 15.54 15.38 15.80 2.73
Jul 26 15.70 15.50 16.08 3.74
Jul 27 15.76 15.44 15.90 3.00
Jul 28 15.59 15.39 15.77 2.52
Jul 29 15.68 15.55 15.88 2.09
Jul 30 15.89 15.70 16.17 3.01
Jul 31 16.23 16.11 16.44 2.03
Aug 01 16.35 16.00 16.54 3.37
Aug 02 16.22 16.12 16.46 2.11
Aug 03 16.25 15.87 16.43 3.53
Aug 04 16.20 15.92 16.50 3.63
Aug 05 15.91 15.60 16.28 4.34
Aug 06 15.99 15.84 16.27 2.72
Aug 07 16.20 15.84 16.38 3.41

Biohaven Pharmaceutical Holding Daily Price Targets


Biohaven Pharmaceutical Holding Stock Forecast 07-09-2025.

Forecast target price for 07-09-2025: $14.44.
Negative dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 3.177%.
Pessimistic target level: 14.13
Optimistic target level: 14.59

Biohaven Pharmaceutical Holding Stock Forecast 07-10-2025.

Forecast target price for 07-10-2025: $14.28.
Negative dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 3.735%.
Pessimistic target level: 14.02
Optimistic target level: 14.57

Biohaven Pharmaceutical Holding Stock Forecast 07-11-2025.

Forecast target price for 07-11-2025: $14.34.
Positive dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 2.778%.
Pessimistic target level: 14.15
Optimistic target level: 14.56

Biohaven Pharmaceutical Holding Stock Forecast 07-12-2025.

Forecast target price for 07-12-2025: $14.52.
Positive dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 3.189%.
Pessimistic target level: 14.28
Optimistic target level: 14.75

Biohaven Pharmaceutical Holding Stock Forecast 07-13-2025.

Forecast target price for 07-13-2025: $14.34.
Negative dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 2.999%.
Pessimistic target level: 14.06
Optimistic target level: 14.49

Biohaven Pharmaceutical Holding Stock Forecast 07-14-2025.

Forecast target price for 07-14-2025: $14.36.
Positive dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 2.709%.
Pessimistic target level: 14.23
Optimistic target level: 14.63

BHVN (BHVN) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jul. 14.79 14.13 15.88 11.06
Jul. 14.48 13.50 15.44 12.59
Aug. 14.29 13.11 15.02 12.67
Oct. 14.70 13.60 15.88 14.36
Oct. 14.46 13.71 15.41 11.04
Dec. 15.27 14.11 16.26 13.22
Dec. 15.51 14.64 16.53 11.45

Biohaven Pharmaceutical Holding forecast for this year


Biohaven Pharmaceutical Holding Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $14.7937. Pessimistic: $14.13. Optimistic: $15.88


Biohaven Pharmaceutical Holding Stock Prediction for Jul 2025

An downtrend is forecast for this month with an optimal target price of $14.4845. Pessimistic: $13.50. Optimistic: $15.44


Biohaven Pharmaceutical Holding Stock Prediction for Aug 2025

An downtrend is forecast for this month with an optimal target price of $14.2933. Pessimistic: $13.11. Optimistic: $15.02


Biohaven Pharmaceutical Holding Stock Prediction for Oct 2025

An uptrend is forecast for this month with an optimal target price of $14.7021. Pessimistic: $13.60. Optimistic: $15.88


Biohaven Pharmaceutical Holding Stock Prediction for Oct 2025

An downtrend is forecast for this month with an optimal target price of $14.4595. Pessimistic: $13.71. Optimistic: $15.41


Biohaven Pharmaceutical Holding Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $15.2707. Pessimistic: $14.11. Optimistic: $16.26


Biohaven Pharmaceutical Holding Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $15.5059. Pessimistic: $14.64. Optimistic: $16.53



Biohaven Pharmaceutical Holding (BHVN) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 15.35 14.88 16.53 10.01
Mar 16.18 15.45 16.93 8.73
Mar 15.09 14.68 15.71 6.55
May 15.36 14.75 16.15 8.68
May 14.79 13.92 15.45 9.89
Jul 16.10 15.75 17.22 8.54
Jul 15.47 14.43 16.60 13.11
Aug 14.89 13.87 15.49 10.46
Oct 14.95 14.20 15.59 8.97
Oct 14.62 13.96 15.80 11.61
Dec 15.15 14.52 16.19 10.30
Dec 15.17 14.57 16.19 10.00

Biohaven Pharmaceutical Holding (BHVN) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 15.50 14.14 16.58 14.71
Mar 15.86 15.27 16.28 6.22
Mar 15.15 14.13 16.16 12.58
May 13.81 13.22 14.98 11.76
May 13.97 12.77 14.40 11.31
Jul 14.23 13.91 15.39 9.56
Jul 14.09 13.14 15.05 12.67
Aug 15.64 15.17 16.03 5.36
Oct 16.19 14.83 17.04 12.96
Oct 15.47 15.12 16.36 7.60
Dec 14.95 14.12 15.98 11.62
Dec 15.46 14.69 16.22 9.43

Biohaven Pharmaceutical Holding information and performance

Biohaven Pharmaceutical Holding Address

215 CHURCH STREET, NEW HAVEN, CT, US

Market Capitalization: 1 505 146 000 $

Market capitalization of the Biohaven Pharmaceutical Holding Company Ltd. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BHVN shares in the company outstanding by the market price of one share.

EBITDA: -903 876 992 $

EBITDA of Biohaven Pharmaceutical Holding is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -9.25

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -2.188

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 102113000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Biohaven Pharmaceutical Holding Stock)

Should I Buy Biohaven Pharmaceutical Holding Shares in 2025 year?

The maximum forecasted share price for next year is $16.18, which is $1.55 higher than the current stock price. By investing in Biohaven Pharmaceutical Holding shares today for a one-year period, you could achieve a profit of 10.59%. With an investment horizon of up to two years, the target share price is $16.19. resulting in a profit of 10.64% ($1.56 per share).

Does Biohaven Pharmaceutical Holding pay dividends?

No, it does not

Which economic sector do Biohaven Pharmaceutical Holding's shares belong to?

Biohaven Pharmaceutical Holding's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Biohaven Pharmaceutical Holding's shares?

You can view all the stocks that are part of the same sector as Biohaven Pharmaceutical Holding's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.